Precursor forms of Vitamin D reduce HIV-1 infection in vitro

ABSTRACT: Background: Although the anti-HIV-1 effects of vitamin D (VitD) have been reported, mechanisms behind such protection remain largely unexplored. Methods: The effects of two precursor forms (cholecalciferol/calciol at 0.01, 1 and 100 nM and calcidiol at 100 and 250 nM) on HIV-1 infection, i...

Full description

Autores:
Aguilar Jiménez, Wbeimar
Villegas Ospina, Simón
González Díaz, Sandra Milena
Zapata Builes, Wildeman
Saulle, Irma
Garziano, Micaela
Biasin, Mara
Clerici, Mario
Rugeles López, María Teresa
Tipo de recurso:
Article of investigation
Fecha de publicación:
2016
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/29861
Acceso en línea:
https://hdl.handle.net/10495/29861
Palabra clave:
VIH-1
HIV-1
ADP-Ribosil Ciclasa 1
ADP-ribosyl Cyclase 1
Vitamina D
Vitamin D
Linfocitos T
T-Lymphocytes
Antígenos HLA-DR
HLA-DR Antigens
CD38
Rights
openAccess
License
http://creativecommons.org/licenses/by-nc-nd/2.5/co/
id UDEA2_c84bc8d5f2f791e5a50c218b55b1c452
oai_identifier_str oai:bibliotecadigital.udea.edu.co:10495/29861
network_acronym_str UDEA2
network_name_str Repositorio UdeA
repository_id_str
dc.title.spa.fl_str_mv Precursor forms of Vitamin D reduce HIV-1 infection in vitro
title Precursor forms of Vitamin D reduce HIV-1 infection in vitro
spellingShingle Precursor forms of Vitamin D reduce HIV-1 infection in vitro
VIH-1
HIV-1
ADP-Ribosil Ciclasa 1
ADP-ribosyl Cyclase 1
Vitamina D
Vitamin D
Linfocitos T
T-Lymphocytes
Antígenos HLA-DR
HLA-DR Antigens
CD38
title_short Precursor forms of Vitamin D reduce HIV-1 infection in vitro
title_full Precursor forms of Vitamin D reduce HIV-1 infection in vitro
title_fullStr Precursor forms of Vitamin D reduce HIV-1 infection in vitro
title_full_unstemmed Precursor forms of Vitamin D reduce HIV-1 infection in vitro
title_sort Precursor forms of Vitamin D reduce HIV-1 infection in vitro
dc.creator.fl_str_mv Aguilar Jiménez, Wbeimar
Villegas Ospina, Simón
González Díaz, Sandra Milena
Zapata Builes, Wildeman
Saulle, Irma
Garziano, Micaela
Biasin, Mara
Clerici, Mario
Rugeles López, María Teresa
dc.contributor.author.none.fl_str_mv Aguilar Jiménez, Wbeimar
Villegas Ospina, Simón
González Díaz, Sandra Milena
Zapata Builes, Wildeman
Saulle, Irma
Garziano, Micaela
Biasin, Mara
Clerici, Mario
Rugeles López, María Teresa
dc.subject.decs.none.fl_str_mv VIH-1
HIV-1
ADP-Ribosil Ciclasa 1
ADP-ribosyl Cyclase 1
Vitamina D
Vitamin D
Linfocitos T
T-Lymphocytes
Antígenos HLA-DR
HLA-DR Antigens
topic VIH-1
HIV-1
ADP-Ribosil Ciclasa 1
ADP-ribosyl Cyclase 1
Vitamina D
Vitamin D
Linfocitos T
T-Lymphocytes
Antígenos HLA-DR
HLA-DR Antigens
CD38
dc.subject.proposal.spa.fl_str_mv CD38
description ABSTRACT: Background: Although the anti-HIV-1 effects of vitamin D (VitD) have been reported, mechanisms behind such protection remain largely unexplored. Methods: The effects of two precursor forms (cholecalciferol/calciol at 0.01, 1 and 100 nM and calcidiol at 100 and 250 nM) on HIV-1 infection, immune activation, and gene expression were analyzed in vitro in cells of Colombian and Italian healthy donors. We quantified levels of released p24 by enzyme-linked immunosorbent assay, of intracellular p24 and cell-surface expression of CD38 and HLA-DR by flow cytometry, and mRNA expression of antiviral and immunoregulatory genes by real-time reverse transcription-polymerase chain reaction. Results: Cholecalciferol decreased the frequency of HIV-1-infected p24CD4 T cells and levels of p24 in supernatants in a dose-dependent manner. Moreover, the CD4CD38HLA-DR and CD4CD38HLA-DR subpopulations were more susceptible to infection but displayed the greatest cholecalciferol-induced decreases in infection rate by an X4-tropic strain. Likewise, cholecalciferol at its highest concentration decreased the frequency of CD38HLA-DR but not of CD38HLA-DR T-cell subsets. Analyzing the effects of calcidiol, the main VitD source for immune cells and an R5-tropic strain as the most frequently transmitted virus, a reduction in HIV-1 productive infection was also observed. In addition, an increase in mRNA expression of APOBEC3G and PI3 and a reduction of TRIM22 and CCR5 expression, this latter positively correlated with p24 levels, was noted. Conclusions: VitD reduces HIV-1 infection in T cells possibly by inducing antiviral gene expression, reducing the viral co-receptor CCR5 and, at least at the highest cholecalciferol concentration, by promoting an HIV-1-restrictive CD38HLA-DR immunophenotype.
publishDate 2016
dc.date.issued.none.fl_str_mv 2016
dc.date.accessioned.none.fl_str_mv 2022-07-25T20:29:55Z
dc.date.available.none.fl_str_mv 2022-07-25T20:29:55Z
dc.type.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.hasversion.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.redcol.spa.fl_str_mv https://purl.org/redcol/resource_type/ART
dc.type.local.spa.fl_str_mv Artículo de investigación
format http://purl.org/coar/resource_type/c_2df8fbb1
status_str publishedVersion
dc.identifier.citation.spa.fl_str_mv Aguilar-Jiménez W, Villegas-Ospina S, González S, Zapata W, Saulle I, Garziano M, Biasin M, Clerici M, Rugeles MT. Precursor Forms of Vitamin D Reduce HIV-1 Infection In Vitro. J Acquir Immune Defic Syndr. 2016 Dec 15;73(5):497-506. doi: 10.1097/QAI.0000000000001150.
dc.identifier.issn.none.fl_str_mv 1525-4135
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/10495/29861
dc.identifier.doi.none.fl_str_mv 10.1097/QAI.0000000000001150
dc.identifier.eissn.none.fl_str_mv 1944-7884
identifier_str_mv Aguilar-Jiménez W, Villegas-Ospina S, González S, Zapata W, Saulle I, Garziano M, Biasin M, Clerici M, Rugeles MT. Precursor Forms of Vitamin D Reduce HIV-1 Infection In Vitro. J Acquir Immune Defic Syndr. 2016 Dec 15;73(5):497-506. doi: 10.1097/QAI.0000000000001150.
1525-4135
10.1097/QAI.0000000000001150
1944-7884
url https://hdl.handle.net/10495/29861
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.ispartofjournalabbrev.spa.fl_str_mv J. Acquir. Immune Defic. Syndr.
dc.rights.spa.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.uri.*.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.rights.accessrights.spa.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.creativecommons.spa.fl_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc-nd/2.5/co/
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.format.extent.spa.fl_str_mv 10
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Williams & Wilkins
dc.publisher.group.spa.fl_str_mv Inmunovirología
dc.publisher.place.spa.fl_str_mv Hagerstown, Estados Unidos
institution Universidad de Antioquia
bitstream.url.fl_str_mv https://bibliotecadigital.udea.edu.co/bitstream/10495/29861/2/license_rdf
https://bibliotecadigital.udea.edu.co/bitstream/10495/29861/3/license.txt
https://bibliotecadigital.udea.edu.co/bitstream/10495/29861/1/AguilarWbeimar_2016_PrecursorFormsVitaminD.pdf
bitstream.checksum.fl_str_mv b88b088d9957e670ce3b3fbe2eedbc13
8a4605be74aa9ea9d79846c1fba20a33
31bb0d1cdb0a23e71554efb1c791387c
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional Universidad de Antioquia
repository.mail.fl_str_mv andres.perez@udea.edu.co
_version_ 1805390146688778240
spelling Aguilar Jiménez, WbeimarVillegas Ospina, SimónGonzález Díaz, Sandra MilenaZapata Builes, WildemanSaulle, IrmaGarziano, MicaelaBiasin, MaraClerici, MarioRugeles López, María Teresa2022-07-25T20:29:55Z2022-07-25T20:29:55Z2016Aguilar-Jiménez W, Villegas-Ospina S, González S, Zapata W, Saulle I, Garziano M, Biasin M, Clerici M, Rugeles MT. Precursor Forms of Vitamin D Reduce HIV-1 Infection In Vitro. J Acquir Immune Defic Syndr. 2016 Dec 15;73(5):497-506. doi: 10.1097/QAI.0000000000001150.1525-4135https://hdl.handle.net/10495/2986110.1097/QAI.00000000000011501944-7884ABSTRACT: Background: Although the anti-HIV-1 effects of vitamin D (VitD) have been reported, mechanisms behind such protection remain largely unexplored. Methods: The effects of two precursor forms (cholecalciferol/calciol at 0.01, 1 and 100 nM and calcidiol at 100 and 250 nM) on HIV-1 infection, immune activation, and gene expression were analyzed in vitro in cells of Colombian and Italian healthy donors. We quantified levels of released p24 by enzyme-linked immunosorbent assay, of intracellular p24 and cell-surface expression of CD38 and HLA-DR by flow cytometry, and mRNA expression of antiviral and immunoregulatory genes by real-time reverse transcription-polymerase chain reaction. Results: Cholecalciferol decreased the frequency of HIV-1-infected p24CD4 T cells and levels of p24 in supernatants in a dose-dependent manner. Moreover, the CD4CD38HLA-DR and CD4CD38HLA-DR subpopulations were more susceptible to infection but displayed the greatest cholecalciferol-induced decreases in infection rate by an X4-tropic strain. Likewise, cholecalciferol at its highest concentration decreased the frequency of CD38HLA-DR but not of CD38HLA-DR T-cell subsets. Analyzing the effects of calcidiol, the main VitD source for immune cells and an R5-tropic strain as the most frequently transmitted virus, a reduction in HIV-1 productive infection was also observed. In addition, an increase in mRNA expression of APOBEC3G and PI3 and a reduction of TRIM22 and CCR5 expression, this latter positively correlated with p24 levels, was noted. Conclusions: VitD reduces HIV-1 infection in T cells possibly by inducing antiviral gene expression, reducing the viral co-receptor CCR5 and, at least at the highest cholecalciferol concentration, by promoting an HIV-1-restrictive CD38HLA-DR immunophenotype.COL001244410application/pdfengWilliams & WilkinsInmunovirologíaHagerstown, Estados Unidosinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_2df8fbb1https://purl.org/redcol/resource_type/ARTArtículo de investigaciónhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by-nc-nd/2.5/co/http://purl.org/coar/access_right/c_abf2https://creativecommons.org/licenses/by-nc-nd/4.0/Precursor forms of Vitamin D reduce HIV-1 infection in vitroVIH-1HIV-1ADP-Ribosil Ciclasa 1ADP-ribosyl Cyclase 1Vitamina DVitamin DLinfocitos TT-LymphocytesAntígenos HLA-DRHLA-DR AntigensCD38J. Acquir. Immune Defic. Syndr.Journal of Acquired Immune Deficiency Syndromes497506735CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8823https://bibliotecadigital.udea.edu.co/bitstream/10495/29861/2/license_rdfb88b088d9957e670ce3b3fbe2eedbc13MD52LICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://bibliotecadigital.udea.edu.co/bitstream/10495/29861/3/license.txt8a4605be74aa9ea9d79846c1fba20a33MD53ORIGINALAguilarWbeimar_2016_PrecursorFormsVitaminD.pdfAguilarWbeimar_2016_PrecursorFormsVitaminD.pdfArtículo de investigaciónapplication/pdf996340https://bibliotecadigital.udea.edu.co/bitstream/10495/29861/1/AguilarWbeimar_2016_PrecursorFormsVitaminD.pdf31bb0d1cdb0a23e71554efb1c791387cMD5110495/29861oai:bibliotecadigital.udea.edu.co:10495/298612022-07-25 15:29:56.461Repositorio Institucional Universidad de Antioquiaandres.perez@udea.edu.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